ketoconazole has been researched along with C gattii Infection in 81 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two patients with cryptococcosis of the CNS were treated with ketoconazole (KTZ), an imidazole derivative with fungistatic properties: they had either failed standard therapy (Amphotericin-B + 5-Fluorocytosine) or suffered intolerable side-effects to it." | 7.68 | Ketoconazole in the treatment of cryptococcosis of the central nervous system. ( Sander, JW; Silvado, CS; Trevisol-Bittencourt, PC; Wittig, EO, 1991) |
| "Experiments are described of the treatment of two patients with cryptococcal meningitis using antifungal drugs and amphotericin B." | 7.68 | Treatment of cryptococcal meningitis with five anti-fungal drugs: the role of amphotericin B. ( Shindo, K, 1990) |
| "I report on a patient with primary cryptococcosis that was successfully treated with oral itraconazole." | 7.68 | Cutaneous cryptococcosis successfully treated with itraconazole. ( Goh, CL, 1993) |
| " Itraconazole was superior to fluconazole in candidosis, cryptococcosis, sporotrichosis and aspergillosis, and to amphotericin B and to flucytosine in candidosis, cryptococcosis and aspergillosis." | 7.68 | In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents. ( Van Cutsem, J, 1992) |
| "A new antifungal triazole, itraconazole (R51211), was compared with ketoconazole in treatment of murine cryptococcosis." | 7.67 | R 51211 (itraconazole) therapy of murine cryptococcosis. ( Ahrens, J; Graybill, JR, 1984) |
| "We studied the efficacy of itraconazole, a new oral triazole, in 33 patients (32 were immunocompromised) with cryptococcosis." | 7.67 | Itraconazole therapy for cryptococcal meningitis and cryptococcosis. ( Denning, DW; Hamilton, JR; Hanson, LH; Stevens, DA; Tucker, RM, 1989) |
| " We compared fluconazole in murine cryptococcosis with ketoconazole and amphotericin B." | 7.67 | Treatment of cryptococcal meningitis in mice with fluconazole. ( Graybill, JR; Palou de Fernandez, E; Patino, MM; Tarbit, MH, 1986) |
| "Ketoconazole was effective in the treatment of cryptococcosis in 3 cats." | 7.67 | Treatment of cryptococcosis in three cats, using ketoconazole. ( Martin, RA; Pentlarge, VW, 1986) |
| "Cryptococcosis affecting the skin and a lymph node in a 1 1/2-year-old cat was treated successfully with ketoconazole as the sole therapeutic agent." | 7.67 | Ketoconazole for successful treatment of cryptococcosis in a cat. ( Schulman, J, 1985) |
| "Five patients received ketoconazole treatment of chronic mucocutaneous candidiasis." | 7.66 | Ketoconazole treatment of chronic mucocutaneous candidiasis. ( Graybill, JR; Herndon, JH; Kniker, WT; Levine, HB, 1980) |
| " Ketoconazole, a new oral imidazole, has therefore been evaluated in a murine model of cryptococcosis." | 7.66 | Ketoconazole therapy of murine cryptococcal meningitis. ( Craven, PC; Graybill, JR; Jorgensen, JH, 1982) |
| "Ketoconazole, amphotericin B, 5-fluorocytosine, and combinations of these drugs were compared as therapy for chronic cryptococcal meningitis in steroid-treated rabbits." | 7.66 | Treatment of experimental cryptococcal meningitis with amphotericin B, 5-fluorocytosine, and ketoconazole. ( Durack, DT; Perfect, JR, 1982) |
| "Systemic cryptococcosis was diagnosed by evaluating a trans-tracheal aspirate and a cryptococcal latex-particle agglutination antigen titer." | 5.28 | Ketoconazole therapy in a dog with systemic cryptococcosis. ( Bachrach, A; Labato, MA; Mason, GD, 1989) |
| " Treatment of invasive aspergillosis required a higher dosage (about 5 mg/kg) and prolonged administration." | 5.28 | Experience with itraconazole in cryptococcosis and aspergillosis. ( Almaviva, M; Cristina, S; De Maria, R; Ferrazzi, P; Fiocchi, R; Langer, M; Negri, C; Scoccia, S; Tortorano, AM; Viviani, MA, 1989) |
| "Ketoconazole has been shown to penetrate into brain tissue of mice and cerebrospinal fluid of humans and to improve the course of human coccidioidal meningitis." | 5.27 | Combination of oral flucytosine and ketoconazole as therapy for experimental cryptococcal meningitis. ( Craven, PC; Graybill, JR, 1984) |
| "Fluconazole was 5-20-fold more active than ketoconazole against systemic aspergillosis and against systemic, intracranial and pulmonary cryptococcosis but was less active than amphotericin B." | 5.27 | Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice. ( Andrews, RJ; Marriott, MS; Richardson, K; Troke, PF, 1987) |
| "The recently developed antifungal agents itraconazole and fluconazole have been evaluated for primary and maintenance therapy for mycoses in patients with acquired immune deficiency syndrome (AIDS) in comparative and non-comparative trials." | 5.07 | Opportunistic fungal infections in patients with acquired immune deficiency syndrome. ( Viviani, MA, 1992) |
| "Experiments are described of the treatment of two patients with cryptococcal meningitis using antifungal drugs and amphotericin B." | 3.68 | Treatment of cryptococcal meningitis with five anti-fungal drugs: the role of amphotericin B. ( Shindo, K, 1990) |
| "The triazole Bay R 3783 was compared with fluconazole, itraconazole, ketoconazole, and amphotericin B in rodent models of superficial and systemic candidiasis, meningocerebral cryptococcosis, and pulmonary aspergillosis." | 3.68 | Evaluation of Bay R 3783 in rodent models of superficial and systemic candidiasis, meningeal cryptococcosis, and pulmonary aspergillosis. ( Hector, RF; Yee, E, 1990) |
| "I report on a patient with primary cryptococcosis that was successfully treated with oral itraconazole." | 3.68 | Cutaneous cryptococcosis successfully treated with itraconazole. ( Goh, CL, 1993) |
| " Itraconazole was superior to fluconazole in candidosis, cryptococcosis, sporotrichosis and aspergillosis, and to amphotericin B and to flucytosine in candidosis, cryptococcosis and aspergillosis." | 3.68 | In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents. ( Van Cutsem, J, 1992) |
| "Two patients with cryptococcosis of the CNS were treated with ketoconazole (KTZ), an imidazole derivative with fungistatic properties: they had either failed standard therapy (Amphotericin-B + 5-Fluorocytosine) or suffered intolerable side-effects to it." | 3.68 | Ketoconazole in the treatment of cryptococcosis of the central nervous system. ( Sander, JW; Silvado, CS; Trevisol-Bittencourt, PC; Wittig, EO, 1991) |
| "A new antifungal triazole, itraconazole (R51211), was compared with ketoconazole in treatment of murine cryptococcosis." | 3.67 | R 51211 (itraconazole) therapy of murine cryptococcosis. ( Ahrens, J; Graybill, JR, 1984) |
| " We examined four issues: the efficacy of treatment with amphotericin plus flucytosine as compared with amphotericin alone, the efficacy of suppressive therapy, the prognostic clinical characteristics, and the course of nonmeningeal cryptococcosis." | 3.67 | Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. ( Chuck, SL; Sande, MA, 1989) |
| "We studied the efficacy of itraconazole, a new oral triazole, in 33 patients (32 were immunocompromised) with cryptococcosis." | 3.67 | Itraconazole therapy for cryptococcal meningitis and cryptococcosis. ( Denning, DW; Hamilton, JR; Hanson, LH; Stevens, DA; Tucker, RM, 1989) |
| "Combination pairs of 5-fluorocytosine (5-FC) + itraconazole (Itra), 5-FC + fluconazole (Fluc), and amphotericin B (Amph B) + Itra were administered to mice with experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis with a variety of combination ratios." | 3.67 | Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice. ( Polak, A, 1987) |
| " We compared fluconazole in murine cryptococcosis with ketoconazole and amphotericin B." | 3.67 | Treatment of cryptococcal meningitis in mice with fluconazole. ( Graybill, JR; Palou de Fernandez, E; Patino, MM; Tarbit, MH, 1986) |
| "A case of cryptococcosis in a woman 46 years old, with lesions of the skin and the lung with an evolution of six years who answered satisfactory to a treatment with ketoconazole." | 3.67 | [Cryptococcosis. Apropos of a case]. ( Fernández Bussy, RA; Pecoraro, V; Reeves, G, 1988) |
| "Ketoconazole was effective in the treatment of cryptococcosis in 3 cats." | 3.67 | Treatment of cryptococcosis in three cats, using ketoconazole. ( Martin, RA; Pentlarge, VW, 1986) |
| "Cryptococcosis affecting the skin and a lymph node in a 1 1/2-year-old cat was treated successfully with ketoconazole as the sole therapeutic agent." | 3.67 | Ketoconazole for successful treatment of cryptococcosis in a cat. ( Schulman, J, 1985) |
| " Ketoconazole, a new oral imidazole, has therefore been evaluated in a murine model of cryptococcosis." | 3.66 | Ketoconazole therapy of murine cryptococcal meningitis. ( Craven, PC; Graybill, JR; Jorgensen, JH, 1982) |
| "Combination pairs of the major systematic antimycotic drugs, amphotericin B (AmphB), 5-fluorocytosine (5-FC) and ketoconazole (Ktz) were administered to mice with experimental candidiasis, cryptococcosis and aspergillosis at a variety of combination ratios." | 3.66 | Combination therapy of experimental candidiasis, cryptococcosis and aspergillosis in mice. ( Polak, A; Scholer, HJ; Wall, M, 1982) |
| "Ketoconazole, amphotericin B, 5-fluorocytosine, and combinations of these drugs were compared as therapy for chronic cryptococcal meningitis in steroid-treated rabbits." | 3.66 | Treatment of experimental cryptococcal meningitis with amphotericin B, 5-fluorocytosine, and ketoconazole. ( Durack, DT; Perfect, JR, 1982) |
| "Five patients received ketoconazole treatment of chronic mucocutaneous candidiasis." | 3.66 | Ketoconazole treatment of chronic mucocutaneous candidiasis. ( Graybill, JR; Herndon, JH; Kniker, WT; Levine, HB, 1980) |
| "Ketoconazole tablets were used with good success in previous years of the AIDS epidemics." | 2.39 | [Therapy of candidiasis and cryptococcosis in AIDS]. ( Just-Nübling, G, 1994) |
| "Invasive fungal infections are common in immunocompromised patients." | 2.38 | [Systemic mycotic infections]. ( Meunier, F, 1990) |
| "The deep mycoses are increasing in importance both as opportunistic infections and from exposure in geographically defined areas." | 2.37 | Cutaneous and mucosal manifestations of the deep mycotic infections. ( Meyer, RD, 1986) |
| "Mycotic pneumonias are common problems seen in small companion animals because of the wide environmental distribution of fungi and their use of airborne spores for reproduction." | 2.37 | Mycotic pneumonias. ( Roudebush, P, 1985) |
| "The substantial early mortality of AIDS-associated disseminated histoplasmosis and the modestly encouraging survival of those who were diagnosed in time to receive adequate therapy raise the issues of surveillance, prophylaxis, and empiric therapy for this infection in selected HIV-positive patients." | 1.28 | Disseminated histoplasmosis in patients with AIDS. ( Burns, DK; Hernandez, JA; Nightingale, SD; Parks, JM; Pounders, SM; Reynolds, J, 1990) |
| " Treatment of invasive aspergillosis required a higher dosage (about 5 mg/kg) and prolonged administration." | 1.28 | Experience with itraconazole in cryptococcosis and aspergillosis. ( Almaviva, M; Cristina, S; De Maria, R; Ferrazzi, P; Fiocchi, R; Langer, M; Negri, C; Scoccia, S; Tortorano, AM; Viviani, MA, 1989) |
| "Data is summarized on six patients with allergic bronchopulmonary aspergillosis, all of whom improved on therapy, and twelve patients with histoplasmosis including eight with AIDS, eleven of whom responded (three newly reported cases are included)." | 1.28 | [The treatment of aspergillosis, cryptococcosis and histoplasmosis in immunocompromised patients. Report of experience in the United States]. ( Hostetler, JS; Stevens, DA, 1991) |
| "Data are summarized on 6 patients with allergic bronchopulmonary aspergillosis, 5 of whom demonstrated marked improvement on therapy, and 12 patients with histoplasmosis including 8 with AIDS, 11 of whom responded and 1 recrudesced on therapy." | 1.28 | US experience with itraconazole in Aspergillus, Cryptococcus and Histoplasma infections in the immunocompromised host. ( Denning, DW; Hostetler, JS; Stevens, DA, 1992) |
| "Systemic cryptococcosis was diagnosed by evaluating a trans-tracheal aspirate and a cryptococcal latex-particle agglutination antigen titer." | 1.28 | Ketoconazole therapy in a dog with systemic cryptococcosis. ( Bachrach, A; Labato, MA; Mason, GD, 1989) |
| "Fluconazole was 5-20-fold more active than ketoconazole against systemic aspergillosis and against systemic, intracranial and pulmonary cryptococcosis but was less active than amphotericin B." | 1.27 | Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice. ( Andrews, RJ; Marriott, MS; Richardson, K; Troke, PF, 1987) |
| "BAY N 7133 was also effective for mouse candidosis by parenteral administration and was effective for guinea pig trichophytosis on topical application." | 1.27 | Antimycotic activity of BAY N 7133 in animal experiments. ( Plempel, M, 1984) |
| "Cryptococcosis is a systemic fungal disease and meningitis is the most serious complication." | 1.27 | Cryptococcal meningitis. ( Tan, CB; Tjia, TL; Yeow, YK, 1985) |
| "Ketoconazole has been shown to penetrate into brain tissue of mice and cerebrospinal fluid of humans and to improve the course of human coccidioidal meningitis." | 1.27 | Combination of oral flucytosine and ketoconazole as therapy for experimental cryptococcal meningitis. ( Craven, PC; Graybill, JR, 1984) |
| "Oral treatment with ketoconazole for 3 months resulted in a complete cure with residual hyperpigmentation and minute scars." | 1.27 | Primary cutaneous cryptococcosis. ( Baes, H; Van Cutsem, J, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 45 (55.56) | 18.7374 |
| 1990's | 31 (38.27) | 18.2507 |
| 2000's | 1 (1.23) | 29.6817 |
| 2010's | 4 (4.94) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garibotto, FM | 1 |
| Garro, AD | 1 |
| Masman, MF | 1 |
| Rodríguez, AM | 1 |
| Luiten, PG | 1 |
| Raimondi, M | 1 |
| Zacchino, SA | 1 |
| Somlai, C | 1 |
| Penke, B | 1 |
| Enriz, RD | 1 |
| Du, W | 1 |
| Li, H | 1 |
| Tian, B | 1 |
| Sai, S | 1 |
| Gao, Y | 1 |
| Lan, T | 1 |
| Meng, Y | 1 |
| Ding, C | 1 |
| Letendre, JA | 1 |
| Boysen, S | 1 |
| Alves, GS | 1 |
| Freire, AK | 1 |
| Bentes, Ados S | 1 |
| Pinheiro, JF | 1 |
| de Souza, JV | 1 |
| Wanke, B | 1 |
| Matsuura, T | 1 |
| Jackisch-Matsuura, AB | 1 |
| Thomson, P | 1 |
| Miranda, G | 1 |
| Silva, V | 1 |
| Langberg, CW | 1 |
| Barkve, H | 1 |
| Tjørstad, K | 1 |
| Sheklakov, ND | 1 |
| Rukavishnikova, VM | 1 |
| Graybill, JR | 6 |
| Ahrens, J | 1 |
| Herndon, JH | 1 |
| Kniker, WT | 1 |
| Levine, HB | 1 |
| Van Der Meer, JW | 1 |
| Keuning, JJ | 1 |
| Scheijgrond, HW | 1 |
| Heykants, J | 1 |
| Van Cutsem, J | 3 |
| Brugmans, J | 1 |
| Perfect, JR | 4 |
| Durack, DT | 3 |
| Hamilton, JD | 1 |
| Gallis, HA | 1 |
| Craven, PC | 2 |
| Jorgensen, JH | 1 |
| Beehler, BA | 1 |
| Polak, A | 2 |
| Scholer, HJ | 1 |
| Wall, M | 1 |
| Legendre, AM | 1 |
| Gompf, R | 1 |
| Bone, D | 1 |
| Stamm, AM | 1 |
| Dismukes, WE | 2 |
| Kaster, SR | 1 |
| Drutz, DJ | 1 |
| Deutsch, PH | 1 |
| Quintiliani, R | 1 |
| Iwen, PC | 1 |
| Miller, NG | 1 |
| McFadden, HW | 1 |
| Plempel, M | 1 |
| Just-Nübling, G | 1 |
| Lamb, DC | 1 |
| Corran, A | 1 |
| Baldwin, BC | 1 |
| Kwon-Chung, J | 1 |
| Kelly, SL | 1 |
| Goh, CL | 1 |
| Brocklebank, J | 1 |
| Burgaleta, C | 1 |
| Fortun Abete, J | 1 |
| Berenguer Berenguer, J | 1 |
| Hough, I | 1 |
| Govender, S | 1 |
| Mutasa, E | 1 |
| Parbhoo, AH | 1 |
| Le Conte, P | 1 |
| Joly, V | 1 |
| Saint-Julien, L | 1 |
| Gillardin, JM | 1 |
| Carbon, C | 1 |
| Yeni, P | 1 |
| Hostetler, JS | 2 |
| Denning, DW | 3 |
| Stevens, DA | 4 |
| Viviani, MA | 6 |
| Bava, AJ | 2 |
| Negroni, R | 2 |
| Schaberg, T | 1 |
| Lode, H | 1 |
| Morris, B | 1 |
| Chan, YF | 1 |
| Reddy, J | 1 |
| Woodgyer, A | 1 |
| Tzerbos, F | 1 |
| Kabani, S | 1 |
| Booth, D | 1 |
| Trevisol-Bittencourt, PC | 1 |
| Sander, JW | 1 |
| Silvado, CS | 1 |
| Wittig, EO | 1 |
| Yee, RW | 1 |
| Tio, FO | 1 |
| Martinez, JA | 1 |
| Held, KS | 1 |
| Shadduck, JA | 1 |
| Didier, ES | 1 |
| Shindo, K | 1 |
| Hector, RF | 1 |
| Yee, E | 1 |
| Medleau, L | 1 |
| Greene, CE | 1 |
| Rakich, PM | 1 |
| Tortorano, AM | 4 |
| Pagano, A | 1 |
| Vigevani, GM | 1 |
| Gubertini, G | 1 |
| Cristina, S | 2 |
| Assaisso, ML | 1 |
| Suter, F | 1 |
| Farina, C | 1 |
| Minetti, B | 1 |
| Tucker, RM | 2 |
| Hanson, LH | 2 |
| Wright, KA | 1 |
| Ritter, W | 1 |
| Meunier, F | 1 |
| Milchgrub, S | 1 |
| Visconti, E | 1 |
| Avellini, J | 1 |
| Nightingale, SD | 1 |
| Parks, JM | 1 |
| Pounders, SM | 1 |
| Burns, DK | 1 |
| Reynolds, J | 1 |
| Hernandez, JA | 1 |
| Kaben, U | 1 |
| Westphal, HJ | 1 |
| Zimmermann, R | 1 |
| Dunker, H | 1 |
| Langer, M | 1 |
| Almaviva, M | 2 |
| Negri, C | 1 |
| Scoccia, S | 1 |
| De Maria, R | 1 |
| Fiocchi, R | 1 |
| Ferrazzi, P | 1 |
| Hamilton, JR | 1 |
| Chuck, SL | 1 |
| Sande, MA | 1 |
| Mason, GD | 1 |
| Labato, MA | 1 |
| Bachrach, A | 1 |
| de Gans, J | 1 |
| Eeftinck Schattenkerk, JK | 1 |
| van Ketel, RJ | 1 |
| Finquelievich, JL | 1 |
| Iovannitti, C | 1 |
| Savani, DV | 1 |
| Palou de Fernandez, E | 1 |
| Patino, MM | 1 |
| Tarbit, MH | 1 |
| Giani, PC | 1 |
| Arici, C | 1 |
| Goglio, A | 1 |
| Crocchiolo, P | 1 |
| Troke, PF | 1 |
| Andrews, RJ | 1 |
| Marriott, MS | 1 |
| Richardson, K | 1 |
| Woenstenborghs, R | 1 |
| Cauwenbergh, G | 1 |
| Fernández Bussy, RA | 1 |
| Reeves, G | 1 |
| Pecoraro, V | 1 |
| Iida, Y | 1 |
| Maehara, K | 1 |
| Okamoto, Y | 1 |
| Mase, K | 1 |
| Uwamori, H | 1 |
| Yonezu, S | 1 |
| Takeuchi, J | 1 |
| Simojo, M | 1 |
| Yasunaga, K | 1 |
| Emms, SG | 1 |
| Meyer, RD | 1 |
| Granier, F | 1 |
| Kanitakis, J | 1 |
| Hermier, C | 1 |
| Zhu, YY | 1 |
| Thivolet, J | 1 |
| Panciera, DL | 1 |
| Bevier, D | 1 |
| Karaffa, CA | 1 |
| Rehm, SJ | 1 |
| Keys, TF | 1 |
| Shadomy, S | 1 |
| Espinel-Ingroff, A | 1 |
| Tartaglione, TA | 1 |
| Roudebush, P | 1 |
| Ogushi, F | 1 |
| Tamura, M | 1 |
| Ozaki, T | 1 |
| Kamei, T | 1 |
| Nakanishi, M | 1 |
| Shimada, H | 1 |
| Kawano, T | 1 |
| Yasuoka, S | 1 |
| Tsubura, E | 1 |
| Pentlarge, VW | 1 |
| Martin, RA | 1 |
| Seeliger, HP | 1 |
| Tjia, TL | 1 |
| Yeow, YK | 1 |
| Tan, CB | 1 |
| Schulman, J | 1 |
| Baes, H | 1 |
11 reviews available for ketoconazole and C gattii Infection
| Article | Year |
|---|---|
[Imidazole preparations in mycology].
Topics: Animals; Antifungal Agents; Candidiasis; Clotrimazole; Coccidioidomycosis; Cryptococcosis; Dermatomy | 1984 |
Current therapy of pulmonary and disseminated fungal diseases.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Chromoblastomycosis; C | 1983 |
Ketoconazole.
Topics: Candidiasis; Candidiasis, Chronic Mucocutaneous; Candidiasis, Oral; Chemical Phenomena; Chemistry; C | 1984 |
[Therapy of candidiasis and cryptococcosis in AIDS].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Candidiasis, Oral; Cryptococc | 1994 |
[Prevention and treatment of invasive mycoses in patients with neutropenia and bone marrow transplantation].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Candidia | 1995 |
[Diagnosis, treatment and prevention of infections caused by fungi in HIV-positive patients].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Cand | 1995 |
[Commonly used antifungal agents in the treatment of systemic mycoses].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Clinical Trials as Top | 1995 |
[Therapy of pulmonary mycoses].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Blastomy | 1992 |
[Systemic mycotic infections].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Fluconazole; Humans; | 1990 |
Cutaneous and mucosal manifestations of the deep mycotic infections.
Topics: Amphotericin B; Aspergillosis; Blastomycosis; Candidiasis; Candidiasis, Cutaneous; Coccidioidomycosi | 1986 |
Mycotic pneumonias.
Topics: Amphotericin B; Animals; Aspergillosis; Blastomycosis; Cat Diseases; Cats; Coccidioidomycosis; Crypt | 1985 |
1 trial available for ketoconazole and C gattii Infection
| Article | Year |
|---|---|
Opportunistic fungal infections in patients with acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candidiasis; Cryptococcosis; Double-Blind Met | 1992 |
69 other studies available for ketoconazole and C gattii Infection
| Article | Year |
|---|---|
New small-size peptides possessing antifungal activity.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; Candida albicans; Candidiasis; Cryptococcosis; Cryp | 2010 |
Development of nose-to-brain delivery of ketoconazole by nanostructured lipid carriers against cryptococcal meningoencephalitis in mice.
Topics: Administration, Intranasal; Animals; Antifungal Agents; Blood-Brain Barrier; Brain; Cryptococcosis; | 2019 |
Cranial vena cava syndrome secondary to cryptococcal mediastinal granuloma in a cat.
Topics: Animals; Antifungal Agents; Antihypertensive Agents; Cat Diseases; Cats; Chylothorax; Cryptococcosis | 2015 |
Molecular typing of environmental Cryptococcus neoformans/C. gattii species complex isolates from Manaus, Amazonas, Brazil.
Topics: Amphotericin B; Animals; Antifungal Agents; Birds; Brazil; Cryptococcosis; Cryptococcus gattii; Cryp | 2016 |
[Canine lymphadenitis caused by Cryptococcus neoformans. First case in Chile].
Topics: Animals; Antifungal Agents; Chile; Cryptococcosis; Dog Diseases; Dogs; Ketoconazole; Lymphadenitis; | 2006 |
[Cryptococcus neoformans meningoencephalitis].
Topics: Aged; Amphotericin B; Antifungal Agents; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Hum | 1984 |
R 51211 (itraconazole) therapy of murine cryptococcosis.
Topics: Administration, Oral; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Resi | 1984 |
Ketoconazole treatment of chronic mucocutaneous candidiasis.
Topics: Adolescent; Adult; Candidiasis; Candidiasis, Chronic Mucocutaneous; Candidiasis, Oral; Cryptococcosi | 1980 |
The influence of gastric acidity on the bio-availability of ketoconazole.
Topics: Adult; Antifungal Agents; Biological Availability; Cimetidine; Cryptococcosis; Female; Gastric Acid; | 1980 |
Failure of ketoconazole in cryptococcal meningitis.
Topics: Antigens, Fungal; Cerebrospinal Fluid; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Mic | 1982 |
Ketoconazole therapy of murine cryptococcal meningitis.
Topics: Animals; Antifungal Agents; Brain; Cryptococcosis; Cryptococcus neoformans; Female; Imidazoles; Keto | 1982 |
Treatment of experimental cryptococcal meningitis with amphotericin B, 5-fluorocytosine, and ketoconazole.
Topics: Amphotericin B; Animals; Cryptococcosis; Cryptococcus neoformans; Cytosine; Drug Synergism; Drug The | 1982 |
Oral therapy for nasal cryptococcosis in a cheetah.
Topics: Acinonyx; Administration, Oral; Animals; Carnivora; Cryptococcosis; Female; Imidazoles; Ketoconazole | 1982 |
Combination therapy of experimental candidiasis, cryptococcosis and aspergillosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Synergi | 1982 |
Treatment of feline cryptococcosis with ketoconazole.
Topics: Animals; Antifungal Agents; Cat Diseases; Cats; Cryptococcosis; Imidazoles; Ketoconazole; Male; Nose | 1982 |
Comparative activities of Bay n7133, ICI 153,066, and ketoconazole in murine cryptococcosis.
Topics: Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Female; Ketoconazole; Male; Mic | 1983 |
Combination of oral flucytosine and ketoconazole as therapy for experimental cryptococcal meningitis.
Topics: Amphotericin B; Animals; Cryptococcosis; Cryptococcus neoformans; Cytosine; Drug Synergism; Drug The | 1984 |
Treatment of murine pulmonary cryptococcosis with ketoconazole and amphotericin B.
Topics: Amphotericin B; Animals; Cryptococcosis; Drug Therapy, Combination; Immunosuppression Therapy; Ketoc | 1984 |
Antimycotic activity of BAY N 7133 in animal experiments.
Topics: Administration, Oral; Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Aspergill | 1984 |
Resistant P45051A1 activity in azole antifungal tolerant Cryptococcus neoformans from AIDS patients.
Topics: AIDS-Related Opportunistic Infections; Cryptococcosis; Cryptococcus neoformans; Cytochrome P-450 Enz | 1995 |
Cutaneous cryptococcosis successfully treated with itraconazole.
Topics: Administration, Oral; Aged; Antifungal Agents; Cryptococcosis; Dermatomycoses; Humans; Itraconazole; | 1993 |
Systemic antifungal drugs.
Topics: Amphotericin B; Anorexia; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidioidom | 1997 |
British Columbia. Canine Cryptococcus neoformans.
Topics: Animals; British Columbia; Cryptococcosis; Dog Diseases; Dogs; Female; Ketoconazole | 1997 |
Cryptococcosis in an eastern water skink.
Topics: Amphotericin B; Animals; Anti-Infective Agents; Antifungal Agents; Cryptococcosis; Enrofloxacin; Flu | 1998 |
Cryptococcal osteomyelitis of the spine.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agent | 1999 |
Tissue distribution and antifungal effect of liposomal itraconazole in experimental cryptococcosis and pulmonary aspergillosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain; Cryptococcosis; Cryptococcu | 1992 |
US experience with itraconazole in Aspergillus, Cryptococcus and Histoplasma infections in the immunocompromised host.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Antifungal Agents; Aspergillosis, Allergic Bronchop | 1992 |
In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy | 1992 |
Comparative study of six antifungal treatments in an experimental model of murine cryptococcosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disease Models, | 1992 |
Cryptococcal peritonitis in a CAPD patient.
Topics: Cryptococcosis; Female; Fluconazole; Humans; Ketoconazole; Middle Aged; Peritoneal Dialysis, Continu | 1992 |
Cryptococcosis as an exclusive oral presentation.
Topics: Acquired Immunodeficiency Syndrome; Cryptococcosis; Humans; Ketoconazole; Male; Middle Aged; Mouth D | 1992 |
[Mycoses as opportunistic infections in AIDS patients].
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; H | 1991 |
[The treatment of aspergillosis, cryptococcosis and histoplasmosis in immunocompromised patients. Report of experience in the United States].
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Cry | 1991 |
Ketoconazole in the treatment of cryptococcosis of the central nervous system.
Topics: Aged; Brain Diseases; Cryptococcosis; Humans; Ketoconazole; Male; Middle Aged | 1991 |
Resolution of microsporidial epithelial keratopathy in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Animals; Antifungal Agents; Corneal Diseases; Cryptococco | 1991 |
Treatment of cryptococcal meningitis with five anti-fungal drugs: the role of amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combinatio | 1990 |
Evaluation of Bay R 3783 in rodent models of superficial and systemic candidiasis, meningeal cryptococcosis, and pulmonary aspergillosis.
Topics: Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Crypto | 1990 |
Evaluation of ketoconazole and itraconazole for treatment of disseminated cryptococcosis in cats.
Topics: Animals; Antigens, Fungal; Cat Diseases; Cats; Cryptococcosis; Cryptococcus; Female; Itraconazole; K | 1990 |
European experience with itraconazole in systemic mycoses.
Topics: Antifungal Agents; Aspergillosis; Child; Cryptococcosis; Drug Administration Schedule; Humans; Itrac | 1990 |
Itraconazole in opportunistic mycoses: cryptococcosis and aspergillosis.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus; | 1990 |
The pharmacokinetics of BAY R3783 and its efficacy in the treatment of experimental cryptococcal meningitis.
Topics: Animals; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Itraconazole; Ketoconazole; Meningiti | 1990 |
Granulomatous prostatitis induced by capsule-deficient cryptococcal infection.
Topics: Cryptococcosis; Humans; Ketoconazole; Male; Middle Aged; Prostate; Prostatectomy; Prostatitis | 1990 |
Disseminated histoplasmosis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Actuarial Analysis; Adult; Amphotericin B; Cryptococcosis; Evalu | 1990 |
[Cryptococcosis of the skin].
Topics: Cryptococcosis; Cryptococcus neoformans; Dermatomycoses; Female; Humans; Itraconazole; Ketoconazole; | 1989 |
Experience with itraconazole in cryptococcosis and aspergillosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Cryptoc | 1989 |
Itraconazole therapy for cryptococcal meningitis and cryptococcosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Antigens, Fungal; Cryptococcosis; Cryp | 1989 |
Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Amphotericin B; Cryptococcosis; Cryptococcus neofor | 1989 |
Ketoconazole therapy in a dog with systemic cryptococcosis.
Topics: Animals; Chorioretinitis; Cryptococcosis; Diagnosis, Differential; Dog Diseases; Dogs; Eye Infection | 1989 |
Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy | 1987 |
Itraconazole as maintenance treatment for cryptococcal meningitis in the acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Cryptococcosis; Humans; Itraconazole; Ketocon | 1988 |
Treatment of experimental sub-acute cryptococcosis in the Wistar rat.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain Diseases; Cryptococcosis; Female; Granuloma, Giant | 1988 |
Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits.
Topics: Animals; Candidiasis; Cortisone; Cryptococcosis; Dose-Response Relationship, Drug; Fluconazole; Immu | 1986 |
Treatment of cryptococcal meningitis in mice with fluconazole.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Fluconazole; Ketoconazole; Kinetics; Men | 1986 |
Itraconazole for cryptococcal infection in the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Cryptococcosis; Humans; Itraconazole; Ketocon | 1987 |
Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus | 1987 |
Experience with itraconazole in deep mycoses in northern Italy.
Topics: Antifungal Agents; Aspergillosis; Cryptococcosis; Humans; Itraconazole; Ketoconazole; Sporotrichosis | 1987 |
[Cryptococcosis. Apropos of a case].
Topics: Cryptococcosis; Female; Foot Dermatoses; Humans; Ketoconazole; Middle Aged | 1988 |
[A case of cryptococcal meningitis successfully treated by ketoconazole and amphotericin B combination therapy].
Topics: Adult; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Humans; K | 1986 |
Ketoconazole in the treatment of cryptococcosis in cats.
Topics: Animals; Cat Diseases; Cats; Cryptococcosis; Female; Ketoconazole | 1987 |
Localized cutaneous cryptococcosis successfully treated with ketoconazole.
Topics: Adult; Cryptococcosis; Dermatomycoses; Female; Humans; Ketoconazole; Kidney Transplantation; Postope | 1987 |
Management of cryptococcosis and toxic epidermal necrolysis in a dog.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Dog Diseases; Dogs; Drug Therapy, Combin | 1987 |
The acquired immunodeficiency syndrome and cryptococcosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Cryptococcosis; Humans; Ketoconazole; Male; Meningitis | 1986 |
Treatment of systemic mycoses with ketoconazole: studies of ketoconazole serum levels.
Topics: Blastomycosis; Child, Preschool; Coccidioidomycosis; Cryptococcosis; Histoplasmosis; Humans; Ketocon | 1986 |
[A case of cryptococcal meningitis improved in the treatment of high dose ketoconazole].
Topics: Anemia, Hemolytic, Autoimmune; Cryptococcosis; Female; Humans; Ketoconazole; Lupus Erythematosus, Sy | 1985 |
Treatment of cryptococcosis in three cats, using ketoconazole.
Topics: Animals; Cat Diseases; Cats; Cryptococcosis; Female; Ketoconazole; Male; Nose Diseases | 1986 |
[Prevention of mycoses caused by yeasts].
Topics: Candidiasis; Cryptococcosis; Disinfection; Humans; Infant; Infant, Newborn; Infant, Premature, Disea | 1985 |
Cryptococcal meningitis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Child; Cryptococcosis; Flucytosine; Follow-Up Studies; Garl | 1985 |
Ketoconazole for successful treatment of cryptococcosis in a cat.
Topics: Animals; Cat Diseases; Cats; Cryptococcosis; Dermatomycoses; Ketoconazole; Male | 1985 |
Primary cutaneous cryptococcosis.
Topics: Animals; Asthma; Columbidae; Cryptococcosis; Dermatomycoses; Humans; Immunosuppression Therapy; Keto | 1985 |